ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,059 | -28.8% | 21,499 | +0.1% | 0.00% | – |
| Q2 2023 | $605,753 | +64.0% | 21,488 | +0.2% | 0.00% | – |
| Q1 2023 | $369,292 | +75.5% | 21,452 | +105.2% | 0.00% | – |
| Q4 2022 | $210,371 | -7.4% | 10,453 | -50.0% | 0.00% | – |
| Q3 2022 | $227,227 | -23.0% | 20,904 | +100.0% | 0.00% | – |
| Q2 2022 | $295,000 | – | 10,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |